Concentric Capital Strategies’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-18,271
Closed -$1.4M 246
2023
Q3
$1.4M Buy
+18,271
New +$1.52M 0.14% 126
2023
Q2
Sell
-31,719
Closed -$2.68M 161
2023
Q1
$2.68M Buy
+31,719
New +$2.72M 0.88% 41

Other funds holding EMN

Concentric Capital Strategies's EMN Position: Q4 2023 in Review

Concentric Capital Strategies sold out of Eastman Chemical (EMN) in Q4 2023, closing a stake of 18,271 shares — an estimated $1.4M sold.

Concentric Capital Strategies first reported a position in EMN in Q1 2023 and held it in 2 quarters. The position peaked at $2.68M in Q1 2023. 711 funds tracked by Wall St. Rank hold EMN as of Q4 2023.

  • Concentric Capital Strategies reported no remaining Eastman Chemical position as of Q4 2023 after selling out during the quarter.
  • Concentric Capital Strategies sold 18,271 Eastman Chemical shares in Q4 2023, an estimated $1.4M.
  • Concentric Capital Strategies first reported a position in Eastman Chemical in Q1 2023 and held it in 2 quarters.
  • Concentric Capital Strategies's Eastman Chemical position peaked at $2.68M in Q1 2023.
  • 711 funds tracked by Wall St. Rank held Eastman Chemical as of Q4 2023.

Based on Concentric Capital Strategies's 13F filing for Q4 2023, filed 14 Feb 2024.